+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), End Use and Region with Growth Forecasts, 2025-2033- Product Image
Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), End Use and Region with Growth Forecasts, 2025-2033- Product Image
New

Intravenous Solutions Market Size, Share & Trends Analysis Report by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), End Use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 3934162
REQUEST CUSTOMIZATION
Description Jump to:
The global intravenous solutions market size was valued at USD 12.80 billion in 2024 and is expected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.

IV solutions provide essential nutrients and are a main source of energy. The rising rates of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.

To learn more about this report, Download Free Sample Report

The table below shows the percent distribution of singleton births, by gestational age: U.S., 2014-2022.

Malnutrition is one of the major drivers of the Intravenous (IV) solution market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant’s diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.

Global Intravenous Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global intravenous solutions market report based on type, nutrient, end use and regions:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Nutrients Outlook (Revenue, USD Million, 2021-2033)

  • Carbohydrates
  • Vitamins & Minerals
  • Single-dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Home
  • Hospitals
  • Infusion Centers

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Nutrient
1.2.3. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Number of Premature Births
3.2.1.2. Increasing Incidence of Cancer
3.2.1.3. Increasing Risk of Malnutrition
3.2.1.4. Growing Geriatric Population
3.2.2. Market Restraint Analysis
3.2.2.1. Shortage of Parenteral Nutrition Products
3.2.2.2. Increased Use of Enteral Nutrition
3.2.2.3. High Risk of Infections
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Regulatory Framework
3.2.5.1. Standards and Compliances
3.2.5.1.1. North America
3.2.5.1.2. Europe
3.2.5.1.3. Asia-Pacific
3.2.5.1.4. Latin America
3.2.5.1.5. MEA
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Intravenous Solutions Market: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Type Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (Revenue USD Million)
4.4. Total Parenteral Nutrition
4.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
4.5. Peripheral Parenteral Nutrition
4.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
Chapter 5. Intravenous Solutions Market: Nutrient Estimates & Trend Analysis
5.1. Nutrient Segment Dashboard
5.2. Nutrient Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Nutrient, 2021 to 2033 (Revenue USD Million)
5.4. Carbohydrates
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
5.5. Vitamins & Minerals
5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
5.6. Single-dose Amino Acids
5.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
5.7. Parenteral Lipid Emulsion
5.7.1. Market Revenue Estimates and Forecasts, 2021-2033 Revenue USD Million)
5.8. Others
5.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
Chapter 6. Intravenous Solutions Market: End Use Estimates & Trend Analysis
6.1. End use Segment Dashboard
6.2. End use Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (Revenue USD Million)
6.4. Home
6.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
6.5. Hospitals
6.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
6.6. Infusion Centers
6.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (Revenue USD Million)
Chapter 7. Intravenous Solutions Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market: Key Takeaways
7.3. North America
7.3.1. North America Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamic
7.3.2.2. Regulatory framework
7.3.2.3. Competitive insights
7.3.2.4. U.S. Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamic
7.3.3.2. Regulatory framework
7.3.3.3. Competitive insights
7.3.3.4. Canada Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamic
7.3.4.2. Regulatory framework
7.3.4.3. Competitive insights
7.3.4.4. Mexico Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4. Europe
7.4.1. Europe Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamic
7.4.2.2. Regulatory framework
7.4.2.3. Competitive insights
7.4.2.4. Germany Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.3. UK
7.4.3.1. Key country dynamic
7.4.3.2. Regulatory framework
7.4.3.3. Competitive insights
7.4.3.4. UK Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.4. France
7.4.4.1. Key country dynamic
7.4.4.2. Regulatory framework
7.4.4.3. Competitive insights
7.4.4.4. France Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamic
7.4.5.2. Regulatory framework
7.4.5.3. Competitive insights
7.4.5.4. Italy Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamic
7.4.6.2. Regulatory framework
7.4.6.3. Competitive insights
7.4.6.4. Spain Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.7. Denmark
7.4.7.1. Key country dynamic
7.4.7.2. Regulatory framework
7.4.7.3. Competitive insights
7.4.7.4. Denmark Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.8. Sweden
7.4.8.1. Key country dynamic
7.4.8.2. Regulatory framework
7.4.8.3. Competitive insights
7.4.8.4. Sweden Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamic
7.4.9.2. Regulatory framework
7.4.9.3. Competitive insights
7.4.9.4. Norway Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.2. Japan
7.5.2.1. Key country dynamic
7.5.2.2. Regulatory framework
7.5.2.3. Competitive insights
7.5.2.4. Japan Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.3. China
7.5.3.1. Key country dynamic
7.5.3.2. Regulatory framework
7.5.3.3. Competitive insights
7.5.3.4. China Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.4. India
7.5.4.1. Key country dynamic
7.5.4.2. Regulatory framework
7.5.4.3. Competitive insights
7.5.4.4. India Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamic
7.5.5.2. Regulatory framework
7.5.5.3. Competitive insights
7.5.5.4. South Korea Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamic
7.5.6.2. Regulatory framework
7.5.6.3. Competitive insights
7.5.6.4. Australia Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamic
7.5.7.2. Regulatory framework
7.5.7.3. Competitive insights
7.5.7.4. Thailand Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.6. Latin America
7.6.1. Latin America Intravenous Solutions Market Estimates and Forecasts, 2021-2033 (Revenue USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamic
7.6.2.2. Regulatory framework
7.6.2.3. Competitive insights
7.6.2.4. Brazil Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamic
7.6.3.2. Regulatory framework
7.6.3.3. Competitive insights
7.6.3.4. Argentina Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.7. MEA
7.7.1. MEA Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamic
7.7.2.2. Regulatory framework
7.7.2.3. Competitive insights
7.7.2.4. South Africa Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamic
7.7.3.2. Regulatory framework
7.7.3.3. Competitive insights
7.7.3.4. Saudi Arabia Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamic
7.7.4.2. Regulatory framework
7.7.4.3. Competitive insights
7.7.4.4. UAE Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamic
7.7.5.2. Regulatory framework
7.7.5.3. Competitive insights
7.7.5.4. Kuwait Intravenous Solutions market estimates and forecasts, 2021-2033 (Revenue USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Fresenius Kabi AG
8.5.1.1. Overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. B. Braun SE
8.5.2.1. Overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Baxter
8.5.3.1. Overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Otsuka Pharmaceutical Co., Ltd.
8.5.4.1. Overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Pfizer, Inc.
8.5.5.1. Overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. JW Life Science
8.5.6.1. Overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Vifor Pharma
8.5.7.1. Overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. ICU Medical, Inc.
8.5.8.1. Overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
List of Tables
Table 1. List of abbreviation
Table 2. List of secondary data sources
Table 3. North America Intravenous Solutions market, by country, 2021-2033 (Revenue USD Million)
Table 4. North America Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 5. North America Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 6. North America Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 7. U.S. Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 8. U.S. Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 9. U.S. Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 10. Canada Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 11. Canada Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 12. Canada Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 13. Mexico Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 14. Mexico Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 15. Mexico Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 16. Europe Intravenous Solutions market, by country, 2021-2033 (Revenue USD Million)
Table 17. Europe Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 18. Europe Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 19. Europe Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 20. Germany Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 21. Germany Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 22. Germany Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 23. Germany Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 24. U.K. Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 25. U.K. Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 26. U.K. Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 27. France Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 28. France Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 29. France Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 30. Italy Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 31. Italy Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 32. Italy Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 33. Spain Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 34. Spain Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 35. Spain Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 36. Sweden Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 37. Sweden Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 38. Sweden Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 39. Denmark Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 40. Denmark Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 41. Denmark Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 42. Norway Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 43. Norway Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 44. Norway Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 45. Asia-Pacific Intravenous Solutions market, by country, 2021-2033 (Revenue USD Million)
Table 46. Asia-Pacific Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 47. Asia-Pacific Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 48. Asia-Pacific Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 49. China Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 50. China Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 51. China Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 52. Japan Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 53. Japan Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 54. Japan Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 55. India Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 56. India Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 57. India Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 58. Australia Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 59. Australia Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 60. Australia Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 61. Thailand Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 62. Thailand Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 63. Thailand Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 64. South Korea Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 65. South Korea Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 66. South Korea Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 67. Latin America Intravenous Solutions market, by country, 2021-2033 (Revenue USD Million)
Table 68. Latin America Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 69. Latin America Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 70. Latin America Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 71. Brazil Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 72. Brazil Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 73. Brazil Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 74. Argentina Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 75. Argentina Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 76. Argentina Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 77. MEA Intravenous Solutions market, by country, 2021-2033 (Revenue USD Million)
Table 78. MEA Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 79. MEA Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 80. MEA Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 81. South Africa Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 82. South Africa Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 83. South Africa Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 84. Saudi Arabia Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 85. Saudi Arabia Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 86. Saudi Arabia Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 87. UAE Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 88. UAE Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 89. UAE Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
Table 90. Kuwait Intravenous Solutions market, by type, 2021-2033 (Revenue USD Million)
Table 91. Kuwait Intravenous Solutions market, by nutrient, 2021-2033 (Revenue USD Million)
Table 92. Kuwait Intravenous Solutions market, by end use, 2021-2033 (Revenue USD Million)
List of Figures
Figure 1 Intravenous solutions market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape
Figure 12 Intravenous solutions market dynamics
Figure 13 Intravenous solutions market: PORTER’s analysis
Figure 14 Intravenous solutions market: PESTEL analysis
Figure 15 Intravenous solutions market by type: key takeaways
Figure 16 Intravenous solutions market, by type: market share, 2024 & 2033
Figure 17 Total parenteral nutrition market, 2021-2033 (Revenue USD Million)
Figure 18 Peripheral parenteral nutrition market, 2021-2033 (Revenue USD Million)
Figure 19 Intravenous solutions market, by end-use: key takeaways
Figure 20 Intravenous solutions market, by nutrients: market share, 2024 & 2033
Figure 21 Carbohydrates market, 2021-2033 (Revenue USD Million)
Figure 22 Single dose amino acid solution market, 2021-2033 (Revenue USD Million)
Figure 23 Vitamins and minerals, 2021-2033 (Revenue USD Million)
Figure 24 Parenteral lipid emulsion, 2021-2033 (Revenue USD Million)
Figure 25 Others market, 2021-2033 (Revenue USD Million)
Figure 26 Intravenous solutions market by end use: key takeaways
Figure 27 Intravenous solutions market, by end use: market share, 2024 & 2033
Figure 28 Home market, 2021-2033 (Revenue USD Million)
Figure 29 Hospitals market, 2021-2033 (Revenue USD Million)
Figure 30 Infusion Centers market, 2021-2033 (Revenue USD Million)
Figure 31 Intravenous solutions market revenue, by region, 2024 & 2033 (Revenue USD Million)
Figure 32 Regional marketplace: key takeaways
Figure 33 Regional marketplace: key takeaways
Figure 34 North America intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 35 Key country dynamics
Figure 36 US intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 37 Key country dynamics
Figure 38 Canada intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 39 Europe intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 40 Key country dynamics
Figure 41 UK intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 42 Key country dynamics
Figure 43 Germany intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 44 Key country dynamics
Figure 45 France intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 46 Key country dynamics
Figure 47 Italy intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 48 Key country dynamics
Figure 49 Spain intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 50 Key country dynamics
Figure 51 Denmark intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 52 Key country dynamics
Figure 53 Sweden intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 54 Key country dynamics
Figure 55 Norway intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 56 Asia-Pacific intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 57 Key country dynamics
Figure 58 Japan intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 59 Key country dynamics
Figure 60 China intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 61 Key country dynamics
Figure 62 India intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 63 Key country dynamics
Figure 64 Australia intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 65 Key country dynamics
Figure 66 South Korea intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 67 Key country dynamics
Figure 68 Thailand intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 69 Latin America intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 70 Key country dynamics
Figure 71 Mexico intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 72 Key country dynamics
Figure 73 Brazil intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 74 Key country dynamics
Figure 75 Argentina intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 76 MEA intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 77 Key country dynamics
Figure 78 South Africa intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 79 Key country dynamics
Figure 80 Saudi Arabia intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 81 Key country dynamics
Figure 82 UAE intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 83 Key country dynamics
Figure 84 Kuwait intravenous solutions market, 2021-2033 (Revenue USD Million)
Figure 85 Key company categorization
Figure 86 Heat map analysis
Figure 87 Company market share/position analysis, 2024
Figure 88 Strategy mapping

Companies Mentioned

The key companies profiled in this Intravenous Solutions market report include:
  • Fresenius Kabi AG
  • B. Braun SE
  • Baxter
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer, Inc.
  • JW Life Science
  • Vifor Pharma
  • ICU Medical, Inc.

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 12.8 Billion
Forecasted Market Value ( USD ) by 2033 $ 28.2 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Intravenous Solutions Market Overview, 2025-30 - Product Image

Intravenous Solutions Market Overview, 2025-30

  • Report
  • 101 Pages
  • Global
From
Intravenous Solutions Market Outlook, 2030 - Product Image

Intravenous Solutions Market Outlook, 2030

  • Report
  • 181 Pages
  • Global
From
Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033 - Product Image

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033

  • Report
  • 144 Pages
  • Global
From
Intravenous Solutions Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Intravenous Solutions Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 132 Pages
  • Global
From
Intravenous Solutions Market Report 2025 - Product Image

Intravenous Solutions Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.